How Billionaires Bought Fake Science During the COVID-19 Pandemic
Professor Dave Explains · 2026-10-18
💡 Quick Take
1. The host explains how flawed antibody studies in early 2020 downplayed COVID-19 to match political and financial demands for rapid economic reopening.
2. Researchers claimed the virus had an infection fatality rate (the actual percentage of infected individuals who die from a disease) between 0.1% and 0.2%, making it sound no deadlier than seasonal flu.
3. An airline founder and hedge fund manager quietly funded the Santa Clara antibody research while using a Wall Street Journal editorial to push for an immediate end to lockdowns.
4. Defenders argued these low mortality estimates were accurate, but the underlying research relied on non-random marketing samples, ignored elderly populations, and was contradicted by independent forecasting teams.
5. A rule worth remembering: always trace who pays for a public health study and verify whether its sample truly represents the entire population.
📊 Detailed Explanation
According to the host, early pandemic policy was derailed by politically convenient pseudoscience designed to mimic Donald Trump's messaging that the virus was mild. In April 2020, researchers Jay Bhattacharya and John Ioannidis released antibody studies from Santa Clara and Los Angeles. These papers argued that the infection fatality rate of COVID-19 stood at just 0.1% to 0.2%, putting it squarely in the realm of normal seasonal influenza. The host points out that these findings relied on deeply biased methods. The Santa Clara study recruited subjects through non-random methods, including appeals from Jay's wife telling people the test could help them get back to work without fear. Meanwhile, the Los Angeles study pulled participants strictly from a marketing database. These skewed samples wildly overestimated how many people had already been infected, creating an artificially low fatality percentage that corporate-funded figures then pushed into the national spotlight.
The host traces a direct line between these flawed numbers and financial interests wanting to end public health safeguards. JetBlue airline founder and hedge fund manager Andrew Bogan championed the Santa Clara results in the Wall Street Journal to argue against lockdowns. He never disclosed that he personally funded the study to protect his airline investments. The host notes that the newspaper's editorial board routinely promoted contrarian narratives, including unproven treatments like hydroxychloroquine and ivermectin, while giving a platform to predictions that the United States would see only 20,000 to 40,000 total deaths. When critics pointed out that actual fatalities far exceeded these projections, co-authors like Eran Bendavid conceded they were completely wrong, even while allies attempted to rewrite history and deny those claims had ever been published.
When writers like Zeynep Tufekci challenged these low fatality narratives, co-authors like Martin Kulldorff rallied to defend the work with further distortions. The host explains that Martin tried to validate the 0.2% estimate by citing other studies co-authored by Ioannidis that also used non-random data, failed to track uncounted deaths, and excluded nursing home populations where deaths were highest. Furthermore, these contrarian researchers pushed natural herd immunity strategies while claiming they worked in Sweden, even though Sweden did not follow their recommendations and suffered severe death tolls. Jay similarly overstated natural immunity in India by a factor of two while understating fatality rates by a factor of four. The host argues that this manufactured complacency discouraged masking and vaccination, directly contributing to catastrophic waves of infection abroad.
🎯 Education Expert Opinion
The host delivers an urgent, forensic breakdown of how bad science gets laundered into national policy. From an educational design standpoint, contrasting study claims against their source funding works remarkably well to build critical thinking. Instead of debating abstract virology, the host lays out how biased sampling directly corrupts data outputs. He takes the infection fatality rate and shows how a flawed denominator destroys the credibility of the entire fraction. Pointing out that a test group came from a corporate marketing list turns an abstract research flaw into something any everyday learner can immediately understand.
For students learning scientific literacy, this video offers a strong starting point for identifying research bias and predatory funding. A practical curriculum following this material should first teach basic sampling methods, specifically contrasting convenience samples with truly randomized cohorts. Next, learners need lessons on reading conflict-of-interest disclosures in peer-reviewed journals versus mainstream opinion pieces. The only drawback here is the host's aggressive, emotionally charged delivery. While his factual critiques of the sampling errors and mortality projections are solid, the profanity and intense polemical tone may cause defensive viewers to tune out rather than engage with the statistical evidence.
This content serves adult learners, science students, and media literacy classes that want to unpack real-world disinformation campaigns. The essential lesson here is that academic credentials do not make an author immune to ideological or financial corruption. In everyday life, whenever an expert makes an extraordinary public health claim that promises easy answers, you should immediately ask two things: who paid for the research, and did they pick a representative sample of normal people?
Kanal: Professor Dave Explains